Gadoxetate Disodium

钆塞酸钠

Report date: 2026/01/28 17:54:37
NME

Base Information

Drug NameGadoxetate Disodium
Drug Alias Name钆塞酸二钠Gadoxate disodiumgadoxetic acid钆噻酸二钠EOB Primovist +[15] 
ClassificationDiagnostic agent (In vivo) > Contrast agentSmall molecules
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsDiagnostic agentsProstatic Neoplasms, Castration-Resistant +[7] 
Global Approved IndicationsContrast agentsDiagnostic agents
Approved Indications in ChinaContrast agents
Original Approved Country/TerritorySweden
Original Approved Date2004/03/26
Country/TerritoryUnited StatesSwedenGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGBayer Healthcare Pharmaceuticals Inc
Inactive CompaniesUniversity Of Southern CaliforniaNational Cancer InstituteUniversity Medicine Greifswald +[5] 
Active IndicationsContrast agentsDiagnostic agents
Inactive IndicationsProstatic Neoplasms, Castration-ResistantProstatic NeoplasmsLiver Neoplasms +[5] 

Other Information

ATC CodeV08CA10
Related LinksWikipediaDrugBankKEGG